Recruiting

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or…

ClinicalTrials.gov IDNCT07673380
PhasePHASE2
Enrollment300
SponsorWashington University School of Medicine
Age18 Years and older
SexALL
I'm interested View official listing

Conditions studied

Opioid Use, Stimulant Use, Depression and Anxiety Symptoms

About this study

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Have a history of opioid and/or stimulant use * Identify as Black and/or African American * Seek treatment at local substance use treatment centers * Fluent in English * U.S. resident * 18 years of age or older at the time of data collection. Exclusion Criteria: * Self-reported cognitive impairment that would limit ability to participate in research.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-10-21.